Evidence map›Paper›PMID 40587098›Full record

ArticleAnalytical chemistry2025

Multiple Exposures of Plasma to Nanoparticles: A Novel Tool to Personalize Biomolecular Coronas and Fractionate Fluids.

Alberto Martinez-Serra, Jack Cheeseman, Asia Saorin, Mahmoud G Soliman, Marko Dobricic, Daniel I R Spencer, Marco P Monopoli

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Navigating theNanoscale advances · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alberto Martinez-SerraChemistry Department, Royal College of Surgeons in Ireland (RCSI), 123 St. Stephen's Green, Dublin 2, Ireland.
Jack CheesemanLudger Ltd., Culham Campus, Abingdon OX14 3EB, Oxfordshire, United Kingdom.ORCID 0000-0003-1112-217X
Asia SaorinChemistry Department, Royal College of Surgeons in Ireland (RCSI), 123 St. Stephen's Green, Dublin 2, Ireland.
Mahmoud G SolimanChemistry Department, Royal College of Surgeons in Ireland (RCSI), 123 St. Stephen's Green, Dublin 2, Ireland.
Marko DobricicChemistry Department, Royal College of Surgeons in Ireland (RCSI), 123 St. Stephen's Green, Dublin 2, Ireland.
Daniel I R SpencerLudger Ltd., Culham Campus, Abingdon OX14 3EB, Oxfordshire, United Kingdom.
Marco P MonopoliChemistry Department, Royal College of Surgeons in Ireland (RCSI), 123 St. Stephen's Green, Dublin 2, Ireland.ORCID 0000-0002-2035-6894

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles (NPs) have emerged as a valuable tool for biomarker discovery due to their ability to interact with biological fluids and form biomolecular coronas. In this study, we introduce a multiple exposure method that uses NPs to fractionate biological fluids and obtain personalized coronas. By repeatedly exposing plasma to silica NPs, we observed a progressive change of the biomolecule profile in both the pellet and supernatant. The varying protein and glycan composition of the corona was characterized using techniques such as SDS-PAGE, mass spectrometry, and UHPLC. Notably, the corona's composition evolved with each exposure cycle, reflecting the selective binding of proteins and glycosylated molecules from a corona of high-affinity biomolecules to a more diverse corona with very distinct structures. By tracing the sequential modification of protein and glycan composition, we believe that the method can be useful to trace specific biomarker profiles, offering a noninvasive alternative to conventional diagnostic processes with the potential to become a useful tool for disease monitoring and advanced biomedical applications.

Indexed as

NanoparticlesProtein CoronaBiomarkersChromatography, High Pressure LiquidHumansMass SpectrometryPolysaccharidesSilicon DioxideBiomarkersPolysaccharidesProtein CoronaSilicon Dioxide

Identifiers

PMID40587098
PMCPMC12268827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.